Ovarian Cancer

Showing NaN - NaN of 106

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Pancreatic Cancer, Breast Cancer, Gastric Cancer Trial in United States (NGM831, NGM831 plus pembrolizumab)

Recruiting
  • Pancreatic Cancer
  • +15 more
  • Gilbert, Arizona
  • +4 more
Jun 21, 2022

Ovarian Cancer, Hepatocellular Carcinoma, NSCLC Trial in Canada, United States (DPX-Survivac, Cyclophosphamide, Pembrolizumab)

Active, not recruiting
  • Ovarian Cancer
  • +4 more
  • DPX-Survivac
  • +2 more
  • Tucson, Arizona
  • +22 more
Mar 28, 2022

Ovarian Cancer Trial in Los Angeles (Pembrolizumab, Gemcitabine, Cisplatin)

Completed
  • Ovarian Cancer
  • Los Angeles, California
    Cedars-Sinai Medical Center
Mar 14, 2022

Advanced Solid Tumors, Head Neck Cancer, Pancreatic Cancer Trial in United States (Cabiralizumab, Nivolumab)

Completed
  • Advanced Solid Tumors
  • +6 more
  • Cabiralizumab
  • Nivolumab
  • Scottsdale, Arizona
  • +38 more
Jan 5, 2022

Advanced Solid Tumors, Solid Tumors, Ovarian Cancer Trial in Australia, United States (TALZENNA capsule, Talazoparib soft gel

Active, not recruiting
  • Advanced Solid Tumors
  • +7 more
  • TALZENNA capsule
  • Talazoparib soft gel capsule
  • Encinitas, California
  • +31 more
Feb 14, 2022

Mesothelioma, Bladder Cancer, Melanoma Trial in Australia, Canada, United States (MGD009)

Terminated
  • Mesothelioma
  • +12 more
  • MGD009
  • Los Angeles, California
  • +19 more
Feb 4, 2022

Ovarian Cancer, Epithelial Ovarian Cancer, Fallopian Tube Cancer Trial in Worldwide (Oral rucaparib)

Completed
  • Ovarian Cancer
  • +3 more
  • Oral rucaparib
  • Anchorage, Alaska
  • +74 more
Jan 31, 2022

Advanced Cancer, Ovarian Cancer, Breast Cancer Trial in United States (COM701, COM701 with Opdivo (Nivolumab).)

Recruiting
  • Advanced Cancer
  • +9 more
  • COM701
  • COM701 with Opdivo (Nivolumab).
  • Los Angeles, California
  • +10 more
Jan 25, 2022

Breast Cancer, Ovarian Cancer, Endometrial Cancer Trial in Korea, Republic of, United States (FPA150, Pembrolizumab)

Completed
  • Breast Cancer
  • +3 more
  • FPA150
  • Pembrolizumab
  • Scottsdale, Arizona
  • +17 more
Jan 6, 2022

Ovarian Cancer, Ovarian Carcinoma, Ovary Cancer Trial in Spain, United States (STRO-002)

Recruiting
  • Ovarian Cancer
  • +6 more
  • Tucson, Arizona
  • +25 more
Dec 20, 2021

Cervical Cancer, Gastric Cancer, Stomach Cancer Trial in United States (INCAGN02390)

Completed
  • Cervical Cancer
  • +20 more
  • Los Angeles, California
  • +3 more
Nov 12, 2021

Ovarian Tumors, Ovarian Cancer Trial in Canada, United States (Niraparib)

Completed
  • Ovarian Neoplasms
  • Ovarian Cancer
  • Chandler, Arizona
  • +54 more
Sep 24, 2021

Tumor, Ovarian Cancer Trial in Belgium, United Kingdom, United States (NKTR-102 q14d, NKTR-102 q21d)

Completed
  • Tumor
  • Ovarian Cancer
  • NKTR-102 q14d
  • NKTR-102 q21d
  • Highland, California
  • +19 more
Jul 9, 2021

Brain Tumor, CNS Tumor, Childhood Germ Cell Tumor Trial in Australia, Canada, United States (sodium thiosulfate, examination)

Completed
  • Brain Tumor
  • +8 more
  • sodium thiosulfate
  • examination
  • Birmingham, Alabama
  • +75 more
Jul 1, 2021

Ovarian Cancer Trial in Worldwide (Olaparib, Ceralasertib, Placebo to match olaparib)

Withdrawn
  • Ovarian Cancer
  • Anchorage, Alaska
  • +25 more
Mar 9, 2021

Ovarian Cancer Trial in Worldwide (Pazopanib, Placebo)

Completed
  • Ovarian Cancer
  • Anaheim, California
  • +317 more
Jan 27, 2021

Small-cell Lung Cancer, Soft Tissue Sarcoma, Triple-negative Breast Cancer Trial in Canada, United States (Tinostamustine

Recruiting
  • Small-cell Lung Cancer
  • +4 more
  • Tinostamustine (EDO-S101)
  • Los Angeles, California
  • +7 more
Dec 22, 2020

Ovarian Cancer, Fallopian Tube Cancer, Peritoneal Tumors Trial in Worldwide (EPO906 (Patupilone), doxorubicin)

Completed
  • Ovarian Cancer
  • +2 more
  • Anchorage, Alaska
  • +148 more
Dec 11, 2020

Cervical Cancer, Microsatellite Instability (MSI)-High Endometrial Cancer, Gastric Cancer (Including Stomach and

Completed
  • Cervical Cancer
  • +16 more
  • INCAGN02385
  • Los Angeles, California
  • +3 more
Oct 28, 2020

Epithelial Ovarian Cancer, Primary Peritoneal Carcinoma, Fallopian Tube Cancer Trial in Worldwide (Mirvetuximab soravtansine,

Completed
  • Epithelial Ovarian Cancer
  • +3 more
  • Mirvetuximab soravtansine
  • +3 more
  • Birmingham, Alabama
  • +130 more
Sep 24, 2020

B-cell Malignancies, Colorectal Cancer (CRC), Head Neck Cancer Trial in United Kingdom, United States (Nivolumab (Phase 1),

Completed
  • B-cell Malignancies
  • +7 more
  • Nivolumab (Phase 1)
  • +4 more
  • Birmingham, Alabama
  • +23 more
Aug 26, 2020

Ovarian Cancer Trial in Worldwide (carboplatin, paclitaxel, Avelumab)

Terminated
  • Ovarian Cancer
  • Alabaster, Alabama
  • +319 more
Jun 19, 2020

Ovarian Cancer Trial in United States (Lurbinectedin (PM01183), Pegylated liposomal doxorubicin (PLD), Topotecan)

Completed
  • Ovarian Cancer
  • Lurbinectedin (PM01183)
  • +2 more
  • Peoria, Arizona
  • +27 more
Mar 25, 2020

Melanoma, NSCLC, Squamous Cell Carcinoma of the Head and Neck Trial in United States (PLX3397, Pembrolizumab)

Terminated
  • Melanoma
  • +4 more
  • Scottsdale, Arizona
  • +11 more
Feb 18, 2020